TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes

Cell. 2021 Feb 4;184(3):827-839.e14. doi: 10.1016/j.cell.2020.11.035.


Ahmed and colleagues recently described a novel hybrid lymphocyte expressing both a B and T cell receptor, termed double expresser (DE) cells. DE cells in blood of type 1 diabetes (T1D) subjects were present at increased numbers and enriched for a public B cell clonotype. Here, we attempted to reproduce these findings. While we could identify DE cells by flow cytometry, we found no association between DE cell frequency and T1D status. We were unable to identify the reported public B cell clone, or any similar clone, in bulk B cells or sorted DE cells from T1D subjects or controls. We also did not observe increased usage of the public clone VH or DH genes in B cells or in sorted DE cells. Taken together, our findings suggest that DE cells and their alleged public clonotype are not enriched in T1D. This Matters Arising paper is in response to Ahmed et al. (2019), published in Cell. See also the response by Ahmed et al. (2021), published in this issue.

Keywords: HIRN; HPAP; Human Islet Research Network; Human Pancreas Analysis Program; T1D; immune repertoire; immunoglobulin; immunophenotyping; public clone; rare-event detection; type 1 diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • B-Lymphocytes
  • Clone Cells
  • Diabetes Mellitus, Type 1* / genetics
  • Flow Cytometry
  • Humans
  • Receptors, Antigen, T-Cell


  • Receptors, Antigen, T-Cell